Concepedia

M. Balakrishnan

MB

Statistics

Publications

13

Citations

870

H-Index

13

Active since

2002

Affiliations

Gilead Sciences (United States)(Current)

University of Rochester Medical Center

Inserm

Hindustan Institute of Technology and Science

Centre National de la Recherche Scientifique

M. Balakrishnan is an author at Gilead Sciences (United States) specializing in life sciences, molecular biology, and virology.

ORCID

Publications per year

2002–2025

13

Publications

13

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19

Xuping Xie, Antonio E. Muruato, Xianwen Zhang et al. · Nature Communications · 2020 · 239 citations · Full text

, , +12

Non-Catalytic Site HIV-1 Integrase Inhibitors Disrupt Core Maturation and Induce a Reverse Transcription Block in Target Cells

M. Balakrishnan, Stephen R. Yant, Luong Tsai et al. · PLoS ONE · 2013 · 128 citations · Full text

, , +17

RNase H Active Site Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Design, Biochemical Activity, and Structural Information

Thorsten Kirschberg, M. Balakrishnan, Neil Squires et al. · Journal of Medicinal Chemistry · 2009 · 96 citations · Full text

, , +16

Structural and Binding Analysis of Pyrimidinol Carboxylic Acid and <i>N</i> -Hydroxy Quinazolinedione HIV-1 RNase H Inhibitors

E.B. Lansdon, Qi Liu, Stephanie A. Leavitt et al. · Antimicrobial Agents and Chemotherapy · 2011 · 76 citations · Full text

, , +17

Strand Transfer Occurs in Retroviruses by a Pause-initiated Two-step Mechanism

Ricardo H. Roda, M. Balakrishnan, Jin K. Kim et al. · Journal of Biological Chemistry · 2002 · 64 citations · Full text

, , +13

1–5 of 13